OTC: CHSYF - China Medical System Holdings Limited

Yield per half year: 0%
Dividend yield: +75.79%
Sector: Financials

Company Analysis China Medical System Holdings Limited

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Price (0.9307 $) is less than fair price (1.88 $)
  • Dividends (75.79%) are higher than the sector average (8.37%).
  • The company's current efficiency (ROE=15.47%) is higher than the sector average (ROE=14.9%)

Disadvantages

  • The stock's return over the last year (-38.69%) is lower than the sector average (0.161%).
  • Current debt level 7.34% has increased over 5 years from 6.21%.

Similar companies

KBC Group NV

CaixaBank, S.A.

Banco Bilbao Vizcaya Argentaria, S.A.

Commercial International Bank -Egypt S.A.E

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

China Medical System Holdings Limited Financials Index
7 days 0% -3.6% -3.6%
90 days 0% -44.7% -5.7%
1 year -38.7% 0.2% 12.9%

CHSYF vs Sector: China Medical System Holdings Limited has significantly underperformed the "Financials" sector by -38.85% over the past year.

CHSYF vs Market: China Medical System Holdings Limited has significantly underperformed the market by -51.61% over the past year.

Stable price: CHSYF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.

Long period: CHSYF with weekly volatility of -0.744% over the past year.

3. Summary of the report

3.1. General

P/E: 11.07
P/S: 3.32

3.2. Revenue

EPS 0.9792
ROE 15.47%
ROA 13.54%
ROIC 22.76%
Ebitda margin 44.19%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Below fair price: The current price (0.9307 $) is lower than the fair price (1.88 $).

Price significantly below the fair price: The current price (0.9307 $) is 102% lower than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (11.07) is lower than that of the sector as a whole (27.53).

P/E vs Market: The company's P/E (11.07) is lower than that of the market as a whole (51.38).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (1.71) is higher than that of the sector as a whole (-29.48).

P/BV vs Market: The company's P/BV (1.71) is higher than that of the market as a whole (-9.02).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (3.32) is lower than that of the sector as a whole (7.54).

P/S vs Market: The company's P/S indicator (3.32) is lower than that of the market as a whole (4.71).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (6.66) is higher than that of the sector as a whole (-76.14).

EV/Ebitda vs Market: The company's EV/Ebitda (6.66) is lower than that of the market as a whole (27.8).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Negative and has fallen by -1.02% over the last 5 years.

Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-1.02%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-10.9%).

5.4. ROE

ROE vs Sector: The company's ROE (15.47%) is higher than that of the sector as a whole (14.9%).

ROE vs Market: The company's ROE (15.47%) is higher than that of the market as a whole (5.09%).

5.5. ROA

ROA vs Sector: The company's ROA (13.54%) is lower than that of the sector as a whole (60.57%).

ROA vs Market: The company's ROA (13.54%) is lower than that of the market as a whole (16.55%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (22.76%) is higher than that of the sector as a whole (8.34%).

ROIC vs Market: The company's ROIC (22.76%) is higher than that of the market as a whole (11.03%).

6. Finance

6.1. Assets and debt

Debt level: (7.34%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 6.21% to 7.34%.

Debt Covering: The debt is covered by 54.22% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

High yield: The dividend yield of the company 75.79% is higher than the average for the sector '8.37%.

7.2. Stability and increase in payments

Dividend stability: The company's dividend yield 75.79% has been steadily paid over the past 7 years, DSI=0.86.

Weak dividend growth: The company's dividend yield 75.79% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.

7.3. Payout percentage

Dividend Coverage: Current payments from income (56.66%) are at a comfortable level.

8. Insider trades

8.1. Insider trading

Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

No insider transactions have been recorded yet

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum China Medical System Holdings Limited

9.3. Comments